Karube Y - Search Results

1

Delivery systems for antioxidant nutrients.

Takata J, Matsunaga K, Karube Y. Takata J, et al. Among authors: karube y. Toxicology. 2002 Nov 15;180(2):183-93. doi: 10.1016/s0300-483x(02)00390-6. Toxicology. 2002. PMID: 12324193 Review.

2

Radioactive metal complexes with affinity for tumors. II. Biodistribution of radioactivity in cellular and subcellular fractions of tumor tissues.

Karube Y, Iwamoto K, Miura J, Takata J, Matsushima Y. Karube Y, et al. Chem Pharm Bull (Tokyo). 1989 Jul;37(7):1874-6. doi: 10.1248/cpb.37.1874. Chem Pharm Bull (Tokyo). 1989. PMID: 2509089 Free article.

3

Radioactive metal complexes of ethylenediamine-N,N-diacetic acid. Biodistribution of radioactivity in mice bearing tumors.

Karube Y, Takata J, Yamamoto M, Kono A, Matsushima Y. Karube Y, et al. Chem Pharm Bull (Tokyo). 1984 Oct;32(10):4049-53. doi: 10.1248/cpb.32.4049. Chem Pharm Bull (Tokyo). 1984. PMID: 6442217 No abstract available.

4

Prodrugs of vitamin E. 1. Preparation and enzymatic hydrolysis of aminoalkanecarboxylic acid esters of d-alpha-tocopherol.

Takata J, Karube Y, Nagata Y, Matsushima Y. Takata J, et al. Among authors: karube y. J Pharm Sci. 1995 Jan;84(1):96-100. doi: 10.1002/jps.2600840122. J Pharm Sci. 1995. PMID: 7714753

5

Vitamin K prodrugs: 1. Synthesis of amino acid esters of menahydroquinone-4 and enzymatic reconversion to an active form.

Takata J, Karube Y, Hanada M, Matsunaga K, Matsushima Y, Sendo T, Aoyama T. Takata J, et al. Among authors: karube y. Pharm Res. 1995 Jan;12(1):18-23. doi: 10.1023/a:1016274201137. Pharm Res. 1995. PMID: 7724483

6

Cationic technetium-99m complexes of N-substituted pyridoxal derivatives as renal function agents.

Karube Y, Iwamoto K, Takata J. Karube Y, et al. J Nucl Med. 1994 Oct;35(10):1691-7. J Nucl Med. 1994. PMID: 7931673 Free article.

7

Vitamin K prodrugs: 2. water-soluble prodrugs of menahydroquinone-4 for systemic site-specific delivery.

Takata J, Karube Y, Hanada M, Matsunaga K, Matsushima Y, Sendo T, Oishi R. Takata J, et al. Among authors: karube y. Pharm Res. 1995 Dec;12(12):1973-9. doi: 10.1023/a:1016208409992. Pharm Res. 1995. PMID: 8786976

8

In vitro properties and in vivo behavior of technetium-99m labeled fibrinogens.

Karube Y, Ito S, Katsuno K, Takata J. Karube Y, et al. Ann Nucl Med. 1996 Feb;10(1):63-9. doi: 10.1007/BF03165055. Ann Nucl Med. 1996. PMID: 8814729

9

Radioimmunoscintigraphy using technetium-99m-labeled parental mouse and mouse-human chimeric antibodies to carcinoembryonic antigen in athymic nude mice bearing tumor.

Karube Y, Katsuno K, Takata J, Matsunaga K, Haruno M, Kuroki M, Arakawa F, Matsuoka Y, Kanda H. Karube Y, et al. Nucl Med Biol. 1996 Aug;23(6):753-9. doi: 10.1016/0969-8051(96)00067-4. Nucl Med Biol. 1996. PMID: 8940717

10

Tumor-specific accumulation of 125I-labeled mouse-human chimeric anti-CEA antibody in a xenografted human cancer model demonstrated by whole-body autoradiography and immunostaining.

Haruno M, Kuroki M, Matsunaga K, Takata J, Karube Y, Senba T, Murakami M, Arakawa F, Kuwahara M, Ozaki H, Matsuoka Y, Okazaki M, Kanda H. Haruno M, et al. Among authors: karube y. Nucl Med Biol. 1996 Aug;23(6):821-6. doi: 10.1016/0969-8051(96)00081-9. Nucl Med Biol. 1996. PMID: 8940726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page